A scalable in vitro cell competition model identifies preleukemic super competitor clones
Preleukemic and leukemic conditions are frequently characterized by the acquisition of recurrent genetic mutations in hematopoietic stem cells (HSCs). One of the most frequently mutated genes in both clonal hematopoiesis and myeloid malignancies is the ten-eleven translocation 2 (TET2) gene, which encodes an epigenetic enzyme with a critical role in the regulation of gene transcription. While…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
